Good Morning, Traders!…👋

U.S. stock futures fell Monday as investors looked ahead to June with caution following a strong May performance, amid renewed uncertainty over trade policy and global economic conditions.

President Trump’s tariff agenda remains in the spotlight. Last week, a federal court struck down several of his high-profile duties, including steep tariffs on Chinese imports—only for a higher court to temporarily reinstate them a day later, keeping trade tensions elevated. On Friday, Trump further escalated rhetoric, accusing China of “totally violating its agreement” with the U.S.

Attention now shifts to a crucial week of economic data, headlined by Friday’s May nonfarm payrolls report, which could provide fresh insight into how trade frictions and monetary policy expectations are shaping the labor market and growth outlook.

In other headlines, Elon Musk stepped away from leading DOGE-related initiatives to refocus on Tesla (TSLA), a move that helped boost the stock. Musk’s broader ambitions to restructure the U.S. government through sweeping cuts have since fallen short of his initial $2 trillion goal.

Earnings Watch

Earnings roll out today from Campbell Soup $CPB and Science Applications $SAIC before open, plus Credo Technology $CRDO after close.

Analysts expect Campbell to post $0.66 EPS with packaged food strength, SAIC to hit $1.92 EPS on defense tech growth, and Credo at $0.30 EPS with chip demand.

Happening Today

✓ 09:45 AM ET – S&P Global Manufacturing PMI (May)

✓ 10:00 AM ET – Construction Spending (MoM) (Apr)

✓ 10:00 AM ET - ISM Manufacturing PMI and Prices (May)

✓ 01:00 PM ET – Atlanta Fed GDPNow (Q2)

✓ 01:00 PM ET – Fed Chair Powell Speaks

PREMARKET SNAPSHOT 📈

U.S. equity futures declined this morning as investors reacted to renewed trade tensions and inflation concerns. A federal appeals court reinstated key Trump-era tariffs, reversing a prior decision and heightening uncertainty in U.S.-China trade relations.

SECTOR SNAPSHOT✨

Sector performance was mixed, with gains led by consumer staples and utilities, both showing solid upward momentum. Financials, health care, and real estate edged higher, while materials and industrials held slightly positive. However, consumer discretionary and energy retreated, and information technology dipped after recent strength. Communication services posted a modest gain, adding to its weekly resilience.

PreMarket Unusual Volume Stocks

📈 Brand Engagement Network Inc. ($BNAI) soared 69.68% in pre-market trading with volume surging to 50.21M shares—up a massive 29,571.94%. The stock is drawing strong interest, likely fueled by speculation or recent developments.

📈 Basel Medical Group Ltd ($BMGL) jumped 79.44% with 10.98M shares changing hands—volume spiked 14,645.35%, pointing to growing interest in the healthcare space.

📈 mF International Limited ($MFI) rose 11.45% with 116.45K shares traded—volume climbed 7,052.90%, suggesting renewed attention on this lesser-known name.

📈 Inno Holdings Inc. ($INHD) moved up 9.60% with volume reaching 101.01K, a 1,108.27% increase—indicating possible momentum building.

📈 PLUS THERAPEUTICS, Inc. ($PSTV) gained 36.49% as volume hit 25.75M, up 873.64%—the biotech stock is drawing strong interest, possibly driven by recent news or market buzz.

Premarket Picks

Brand Engagement Network, Inc. (BNAI) is making headlines this morning with a sharp pre-market jump of 87.27%, bringing its price to $0.52. The surge follows the company’s filing of an 8-K form with the SEC, signaling potentially significant developments.

Plus Therapeutics, Inc. (PSTV) is also climbing in pre-market trading, rising 36.42% to $0.39. The gain comes after the company reported its financial results for Q1 2025, offering investors a look at recent performance and outlook.

CERo Therapeutics Holdings, Inc. (CERO) saw its shares rise 17.20% pre-market to $0.52. The move follows news that the company dosed the first patient in its Phase 1 clinical trial of CER-1236, marking a key milestone in its development pipeline.

Blueprint Medicines Corporation (BPMC) experienced a significant 26.80% increase in pre-market price, reaching $128.51. The surge comes after the announcement that Sanofi will acquire Blueprint, a major move in the biotech space.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Knight-Swift Transportation Holdings Inc. (KNX)

Analyst Firm: Goldman Sachs
Upgraded: Neutral to Buy
Price Target: $65
Yesterday's Close: $44.32

Goldman Sachs raised its rating on Knight-Swift from Neutral to Buy and increased its price target to $65, up from the previous $45. Knight-Swift, a major provider of freight transportation services across the U.S. and Mexico, is seeing varied analyst sentiment. Price targets range from a low of $42.00 to a high of $68.00, with a median estimate of $48.50. The average target price stands at $50.11.

2. Nucor Corporation (NUE)

Analyst Firm: BMO Capital
Upgraded: Market Perform to Outperform
Price Target: $145
Yesterday's Close: $109.36

BMO Capital improved its rating on Nucor, moving it from Market Perform to Outperform, and slightly raised the price target to $145 from $140. Nucor, a leader in steel manufacturing and sales, has price targets ranging from $120.00 to $175.00. The median target is $145.00, closely aligning with the average estimate of $144.91, indicating a fairly consistent outlook among analysts.

3. Church & Dwight Co., Inc. (CHD)

Analyst Firm: RBC Capital
Upgraded: Sector Perform to Outperform
Price Target: $114
Yesterday's Close: $98.31

RBC Capital boosted its outlook on Church & Dwight, upgrading it from Sector Perform to Outperform, with a higher price target of $114, compared to the earlier $100. Church & Dwight, known for its household and personal care products, has stock price estimates between $84.00 and $120.00. The median forecast sits at $102.00, with an average target of $102.11, showing a strong consensus on expected performance.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.